Skip to the page

Data / Form D filings / Unite Genomics, Inc.

Unite Genomics, Inc.: Form D filings

Unite Genomics, Inc., a technology company in San Mateo, CA, filed 2 Form D notices with the SEC between 2018 and 2023. The latest, on November 21, 2023, reports $2 million sold of a $2 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3 East Third Street, Suite 200 - #105, San Mateo, CA, 94401
Phone
(510) 408-6842
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1760629

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 21, 2023New notice$2,000,905$2,000,9054Oct 11, 2023sec.gov
Dec 6, 2018New notice$6,192,499$5,782,499$410,0009Nov 21, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Taner DagdelenExecutive Officer, Director
Anthony JosephExecutive Officer, Director

Other technology companies in California that filed recently

Every Form D from the week of Nov 20, 2023 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Unite Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.